These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 24997886

  • 1. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M, Azougagh M, Amood A L-Kamarany M, Bouchafra H, Cherrah Y, Bouklouze A.
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [Abstract] [Full Text] [Related]

  • 2. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
    Azougagh M, Elkarbane M, Bakhous K, Issmaili S, Skalli A, Iben Moussad S, Benaji B.
    Ann Pharm Fr; 2016 Sep; 74(5):358-69. PubMed ID: 27475309
    [Abstract] [Full Text] [Related]

  • 3. Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin.
    Silva TD, Oliveira MA, de Oliveira RB, Vianna-Soares CD.
    J Chromatogr Sci; 2012 Oct; 50(9):831-8. PubMed ID: 22689902
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rapid and sensitive simultaneous determination of ezetimibe and simvastatin from their combination drug products by monolithic silica high-performance liquid chromatographic column.
    Hefnawy M, Al-Omar M, Julkhuf S.
    J Pharm Biomed Anal; 2009 Oct 15; 50(3):527-34. PubMed ID: 19487095
    [Abstract] [Full Text] [Related]

  • 7. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ, Karbhari PA, Bhoir SI, Bindu KS, Das C.
    J Pharm Biomed Anal; 2010 Jul 08; 52(3):362-71. PubMed ID: 19926421
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
    Shah RB, Bryant A, Collier J, Habib MJ, Khan MA.
    Int J Pharm; 2008 Aug 06; 360(1-2):77-82. PubMed ID: 18524511
    [Abstract] [Full Text] [Related]

  • 10. Development of validated stability indicating assay method for simultaneous estimation of metformin hydrochloride and vildagliptin by RP-HPLC.
    Satheeshkumar N, Pradeepkumar M, Shanthikumar S, Rao VJ.
    Drug Res (Stuttg); 2014 Mar 06; 64(3):124-9. PubMed ID: 24081820
    [Abstract] [Full Text] [Related]

  • 11. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
    Vuletić M, Cindrić M, Koruznjak JD.
    J Pharm Biomed Anal; 2005 Apr 01; 37(4):715-21. PubMed ID: 15797793
    [Abstract] [Full Text] [Related]

  • 12. Application of ion-trap mass spectrometry for identification and structural determination of an unknown impurity in simvastatin.
    Reddy GV, Kumar AP, Reddy BV, Sreeramulu J.
    Pharmazie; 2009 Oct 01; 64(10):638-41. PubMed ID: 19947164
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of spectrophotometeric method for simultaneous determination of simvastatin and ezetimibe in tablet formulations.
    Balaji S, Sunitha A.
    Pak J Pharm Sci; 2010 Oct 01; 23(4):375-8. PubMed ID: 20884449
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A UPLC method development and validation study of Upadacitinib and its impurities in extended - release oral tablet dosage forms.
    Nimmagadda RL, Gummadi S.
    Ann Pharm Fr; 2024 Sep 01; 82(5):780-791. PubMed ID: 38554818
    [Abstract] [Full Text] [Related]

  • 16. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.
    Mohammadi A, Rezanour N, Ansari Dogaheh M, Ghorbani Bidkorbeh F, Hashem M, Walker RB.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 01; 846(1-2):215-21. PubMed ID: 17010681
    [Abstract] [Full Text] [Related]

  • 17. Development and validation of reversed phase high performance liquid chromatographic method for determination of moxonidine in the presence of its impurities.
    Milovanović S, Otašević B, Zečević M, Zivanović L, Protić A.
    J Pharm Biomed Anal; 2012 Feb 05; 59():151-6. PubMed ID: 22071445
    [Abstract] [Full Text] [Related]

  • 18. Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
    Jaber AM, Al Sherife HA, Al Omari MM, Badwan AA.
    J Pharm Biomed Anal; 2004 Oct 29; 36(2):341-50. PubMed ID: 15496327
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous quantitation of aspirin, amlodipine and simvastatin in a fixed dose combination of encapsulated tablet formulation by HPLC-UV method.
    Sultan F, Shoaib MH, Yousuf RI, Ahmed FR, Salam FA, Nasiri MI, Khan MA, Manzoor S.
    Pak J Pharm Sci; 2014 Sep 29; 27(5 Spec no):1553-8. PubMed ID: 25176250
    [Abstract] [Full Text] [Related]

  • 20. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR, Yusop Z, Jaafar J, Aris AB, Majid ZA, Umar K, Talib J.
    J Pharm Biomed Anal; 2016 Sep 05; 128():141-148. PubMed ID: 27262107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.